Firms/companies
Hit by wage hike, CIL may hike coal prices
14 Mar 2012
UK trust warns Coal India of legal action
13 Mar 2012
ED launches scan of Antrix-Devas spectrum deal
13 Mar 2012
The ED’s Bangalore zone office has begun the probe to ascertain if any foreign exchange or anti-money laundering laws were contravened when the deal was signed
Azim Premji Trust to sell 1.4% Wipro stake; net Rs1,500 cr
13 Mar 2012
The trust plans to use the money raised through the sale of shares to improve the quality of school education
Pfizer terminates $350-mn insulin marketing deal with Biocon
13 Mar 2012
In a surprise move, US drug giant Pfizer Inc, today called off an insulin distribution agreement with Biocon to sell the Bangalore-based company’s biosimilar versions of the drug in key global markets including the US
Pfizer terminates $350-mn insulin marketing deal with Biocon
13 Mar 2012
In a surprise move, US drug giant Pfizer Inc, today called off an insulin distribution agreement with Biocon to sell the Bangalore-based company’s biosimilar versions of the drug in key global markets including the US
CNN in talks to buy technology news site Mashable for $200 mn: report
13 Mar 2012
If the CNN-Mashable deal goes through, it would be CNN’s biggest acquisition to date, since its acquisition of popular news reader app for Apple’s iPad, Zite in 2011.
CNN in talks to buy technology news site Mashable for $200 mn: report
13 Mar 2012
If the CNN-Mashable deal goes through, it would be CNN’s biggest acquisition to date, since its acquisition of popular news reader app for Apple’s iPad, Zite in 2011.
CNN in talks to buy technology news site Mashable for $200 mn: report
13 Mar 2012
If the CNN-Mashable deal goes through, it would be CNN’s biggest acquisition to date, since its acquisition of popular news reader app for Apple’s iPad, Zite in 2011.
Natco granted compulsory licence for Bayer's Nexavar
12 Mar 2012
The compulsory licence, the first of its kind to be granted in India, enables Natco to sell the drug at up to Rs8,880 for a pack of 120 tablets against Rs284,428 for Bayer's Nexavar
Natco granted compulsory licence for Bayer's Nexavar
12 Mar 2012
The compulsory licence, the first of its kind to be granted in India, enables Natco to sell the drug at up to Rs8,880 for a pack of 120 tablets against Rs284,428 for Bayer's Nexavar
Prudential planning to branch out to Brazil
12 Mar 2012
M&M to close tractor plants for 2 days a week
12 Mar 2012
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
